For other ocular conditions involving pathological neovascularisation or ECM remodelling, such as age-related macular degeneration or glaucoma, Src inhibition might offer a similarly promising approach, particularly given its role in cellular signalling and tissue remodelling. This evidence concerns the gene SRC and age-related macular degeneration.